|
 |
Nome commerciale |
|
|
Trade names are indicative and excipients composition can be different depending on the country and manufacturers
|
|
Amidate |
Stati Uniti d’America |
|
Endatal |
Chile, Messico |
|
Etomidat |
Germania, Lussemburgo, Romania, Svizzera, Ungheria |
|
Etomidate |
Belgio, Colombia, Gran Bretagna, Malaysia, nuova Zelanda, Polonia, Stati Uniti d’America |
|
Etomidato |
Brasile, Chile, Ecuador, Portogallo, Spagna |
|
Hypnomidate |
Austria, Belgio, Brasile, Francia, Germania, Gran Bretagna, Grecia, Iran, Lussemburgo, Paesi Bassi, Polonia, Spagna, Tunisia |
|
Hypnomidato |
Portogallo |
|
Midatus |
Argentina, Chile |
|
Precedex |
Arabia Saudita, Australia, Brasile, Canada, Chile, Colombia, Ecuador, Emirati Arabi Uniti, Giappone, Malaysia, Messico, nuova Zelanda, Perù, Stati Uniti d’America, Venezuela |
|
|
 |
 |
Bibliografia : Etomidate |
|
|
tipo |
pubblicazione |
| 319 |
Rivista |
Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999. |
| 2105 |
Rivista |
Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C.
Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo.
Farm Hosp 1999 ; 23: 357-360. |
| 3372 |
Rivista |
Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Rev Bras Anestesiol 2013 ; 63, 1: 163-166. |
| 5011 |
Laboratorio |
Hypnomidate 2 mg/ml Injection - Summary of Product Characteristics Updated 02-Apr-2024.
Piramal Critical Care Limited 2024 |
| 5042 |
Laboratorio |
Dexdor 100 micrograms/ml concentrate for solution for infusion - Summary of Product Characteristics.
Orion Corporation 2016 |
| 5096 |
Rivista |
Zhang L, Kong L, Deng Q, Chao Y, Fu C, Meng Y.
Compatibility and Stability of Cipepofol (Ciprofol) and Etomidate Mixture for Intravenous Anesthesia.
Current Ther Res 2025 ; 103: 100810. |
|
|
